Premium
Category IV indications for therapeutic apheresis—ASFA fourth special issue
Author(s) -
Shaz Beth H.,
Linenberger Michael L.,
Bandarenko Nicholas,
Winters Jeffrey L.,
Kim Haewon C.,
Marques Marisa B.,
Sarode Ravindra,
Schwartz Joseph,
Weinstein Robert,
Wirk Ashka,
Szczepiorkowski Zbigniew M.
Publication year - 2007
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.20131
Subject(s) - medicine , apheresis , consensus conference , intensive care medicine , clinical practice , therapeutic plasma exchange , family medicine , immunology , surgery , platelet
The American Society for Apheresis (ASFA) Committee on Clinical Applications systematically and critically reviews published information on the use of therapeutic apheresis in clinical practice. On the basis of this review, selected diseases are assigned one of five categories (category I, II, III, IV, and P). The diseases, which were classified as category IV indications, and the rationale for such assignment are reviewed in this article. The diseases assigned to category I, II, III, and newly created category P are discussed in a separate article in this issue. J. Clin. Apheresis, 2007 © 2007 Wiley‐Liss, Inc.